Bayesian Capital Management’s Encore Capital Group ECPG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,371
Closed -$337K 853
2022
Q1
$337K Buy
5,371
+408
+8% +$26.6K 0.05% 488
2021
Q4
$308K Buy
+4,963
New +$279K 0.1% 249
2020
Q3
Sell
-6,616
Closed -$226K 558
2020
Q2
$226K Sell
6,616
-10,003
-60% -$298K 0.05% 415
2020
Q1
$389K Buy
+16,619
New +$559K 0.08% 367
2019
Q3
Sell
-6,100
Closed -$207K 562
2019
Q2
$207K Buy
+6,100
New +$198K 0.04% 430
2019
Q1
Sell
-9,982
Closed -$235K 602
2018
Q4
$235K Sell
9,982
-7,118
-42% -$191K 0.05% 476
2018
Q3
$613K Buy
+17,100
New +$648K 0.1% 283
2018
Q1
Sell
-7,690
Closed -$324K 639
2017
Q4
$324K Buy
+7,690
New +$351K 0.07% 404
2017
Q1
Sell
-12,300
Closed -$352K 479
2016
Q4
$352K Buy
+12,300
New +$301K 0.09% 387

Other funds holding ECPG

Bayesian Capital Management's ECPG Position: Q2 2022 in Review

Bayesian Capital Management sold out of Encore Capital Group (ECPG) in Q2 2022, closing a stake of 5,371 shares — an estimated $337K sold.

Bayesian Capital Management first reported a position in ECPG in Q4 2016 and held it in 9 quarters. The position peaked at $613K in Q3 2018. 214 funds tracked by Wall St. Rank hold ECPG as of Q2 2022.

  • Bayesian Capital Management reported no remaining Encore Capital Group position as of Q2 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 5,371 Encore Capital Group shares in Q2 2022, an estimated $337K.
  • Bayesian Capital Management first reported a position in Encore Capital Group in Q4 2016 and held it in 9 quarters.
  • Bayesian Capital Management's Encore Capital Group position peaked at $613K in Q3 2018.
  • 214 funds tracked by Wall St. Rank held Encore Capital Group as of Q2 2022.

Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.